Shao X, Le Fur S, Cheung W, Belot MP, Perge K, Bouhours-Nouet N, Bensignor C, Levaillant L, Ge B, Kwan T, Lathrop M, Pastinen T, Bougn?res P. CpG methylation changes associated with hyperglycemia in type 1 diabetes occur at angiogenic glomerular and retinal gene loci. Sci Rep. 2025 May 08; 15(1):15999.

Attard TM, Bansal A, Lawson CE, Stoecklein N, Maddux MH. Transition of care in pediatric hereditary polyposis: the why, how and to whom. Expert Rev Gastroenterol Hepatol. 2025 Apr-May; 19(5):527-535.

van den Oever SR, Mulder RL, Oeffinger KC, Gietema JA, Skinner R, Constine LS, Wallace WH, Armenian S, Barnea D, Bardi E, Belle FN, Brown AL, Chemaitilly W, Crowne L, van Dalen EC, Denzer C, Ehrhardt MJ, Felicetti F, Friedman DN, Fulbright J, Glaser AW, Giwercman A, Sangstuen Haugnes H, Hayek S, Hennewig U, van den Heuvel-Eibrink MM, Haupt R, van Iersel L, Kamdar K, Lefrandt J, Levitt G, Morsellino V, Mulrooney DA, Murray RD, Neggers S, Ness KK, Neville KA, Nock NL, Otth M, Prasad PK, van Santen HM, Schindera C, Rath SR, Steinberger J, Terenziani M, Varedi M, Walwyn T, Wei C, Hudson MM, Kremer LCM, Nuver J, Tonorezos E. Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur J Endocrinol. 2025 Mar 27; 192(4):S27-S40.

Cedars A, Manlhiot C, Chinni BK, Opotowsky AR, Becker K, Le A, Khare P, Love Ko J, Everett A, Kutty S, Russell MW, Payne RM, Atz AM, McCrindle BW, Rathod RH, Lewis M, Goldberg D, Hill K, Ploutz M, Detterich J, Schumacher K, Whitehill R, Penny DJ, Cartoski M, Sullivan R, Files M, Garg R, Wagner J, Jacobsen R, Nowlen T, Fletcher S, Conway J, Kim GB, Wu F, Zak V. Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation. J Am Heart Assoc. 2025 Apr; 14(7):e038061.

Marks LJ, Ritter V, Agrusa JE, Kamdar KY, Rivers J, Gardner R, Ehrhardt MJ, Devine KJ, Phillips CA, Reilly A, August K, Weinstein J, Satwani P, Forlenza CJ, Smith CM, Greer C, Afify Z, Lin CH, Belsky JA, Ding H, Hoogstra D, Toner K, Link MP, Schultz LM, Lowe EJ, Aftandilian C. Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.

Shastri VM, Chauhan L, Gbadamosi M, Alonzo TA, Wang YC, Aplenc R, Hirsch BA, Kolb EA, Gamis AS, Meshinchi S, Lamba JK. DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology Group. Clin Cancer Res. 2025 Mar 03; 31(5):890-898.

Stancil SL, Brewe ME, Tumberger J, Bartkoski M, Burns A, Yeh HW, Brucks MG, Bartolotti J, Voss M, Strawn JR, Abdel-Rahman S, Davis A, Brooks WM, Martin LE. Development of a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders: Study protocol for the naltrexone neuroimaging randomized controlled trial (NN-RCT). Contemp Clin Trials. 2025 May; 152:107874.

Frutos AM, Cleary S, Reeves EL, Ahmad HM, Price AM, Self WH, Zhu Y, Safdar B, Peltan ID, Gibbs KW, Exline MC, Lauring AS, Ball SW, DeSilva M, Tartof SY, Dascomb K, Irving SA, Klein NP, Dixon BE, Ong TC, Vaughn IA, House SL, Faryar KA, Nowalk MP, Gaglani M, Wernli KJ, Murugan V, Williams OL, Selvarangan R, Weinberg GA, Staat MA, Halasa NB, Sahni LC, Michaels MG, Englund JA, Kirby MK, Surie D, Dawood FS, Clopper BR, Moline HL, Link-Gelles R, Payne AB, Harker E, Wielgosz K, Weber ZA, Yang DH, Lewis NM, DeCuir J, Olson SM, Chung JR, Flannery B, Grohskopf LA, Reed C, Garg S, Ellington S. Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.

Jarvis J, Chertavian E, Buessing M, Renteria T, Tu L, Hoffer L, Fischer R, Moore A, Cross M, Tones M. The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver survey. Orphanet J Rare Dis. 2025 Feb 21; 20(1):82.

Bahakel H, Spieker AJ, Hayek H, Schuster JE, Hamdan L, Dulek DE, Kitko CL, Stopczynski T, Batarseh E, Haddadin Z, Stewart LS, Stahl A, Potter M, Rahman H, Amarin J, Kalams SA, Bocchini CE, Moulton EA, Coffin SE, Ardura MI, Wattier RL, Maron G, Grimley M, Paulsen G, Harrison CJ, Freedman J, Carpenter PA, Englund JA, Munoz FM, Danziger-Isakov L, Halasa N. Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. J Infect Dis. 2025 Feb 04; 231(1):e123-e131.